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Abstract: Tumour development is a process resulting from the disturbance of 
various cellular functions including cell proliferation, adhesion and motility. 
While the role of these cell parameters in tumour promotion and progression has 
been widely recognized, the mechanisms that influence gap junctional coupling 
during tumorigenesis remain elusive. Neoplastic cells usually display decreased 
levels of connexin expression and/or gap junctional coupling. Thus, impaired 
intercellular communication via gap junctions may facilitate the release of  
a potentially neoplastic cell from the controlling regime of the surrounding 
tissue, leading to tumour promotion. However, recent data indicates that 
metastatic tumour cell lines are often characterized by relatively high levels of 
connexin expression and gap junctional coupling. This review outlines current 
knowledge on the role of connexins in tumorigenesis and the possible 
mechanisms of the interference of gap junctional coupling with the processes of 
tumour invasion and metastasis.    
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GAP JUNCTIONS – THEIR STRUCTURE AND BASIC FUNCTIONS IN 
TISSUE HOMEOSTASIS 
 
Gap junctions are aqueous intercellular channels which directly link the 
cytoplasmic compartments of adjacent cells (Fig. 1). These channels are formed 
upon the docking of two connexons, hexameric hemichannels built of proteins 
belonging to the connexin family [1]. Gap junctions are present in almost all 
vertebrate tissues, where they permit the intercellular exchange of small  
(< 1 kDa) metabolites and second messengers, and thus synchronise cellular 
functions in tissues [2-4]. Representative examples of the synchronising function 
of gap junctional coupling in tissues include electrical and metabolic coupling. 
In the former, gap junctions take part in the intercellular spreading of membrane 
depolarisation by permitting the rapid cell-to-cell transfer of calcium ions 
between cardiac muscle cells [1], or by constituting electrical synapses in the 
nervous system [5]. Metabolic coupling is established when the stimulation of 
one cell is propagated to a cluster of cells through the spreading of active 
substances, such as monosaccharides and cyclic nucleotides [2, 6]. While 
electrical coupling predominantly synchronizes cell functions in excitable 
tissues, metabolic coupling affects the homeostasis of a spectrum of 
multicellular systems, including both excitable and non-excitable tissues.  
 
 
Fig. 1. The structure of gap junctions. Proteins of the connexin family consisting of 
intramembraneous (1-4), extracellular (E1, E2), and intracellular domains (A), compose 
hexameres (connexons; B), which give rise to intercellular channels built of connexons 
contributed by adjacent cells (C). R. Eckert and D. Huelser, private communication, 
modified.  
 
The crucial role of gap junctions in the regulation of tissue homeostasis is 
illustrated by the functional impairment of many vertebrate tissues occurring 
when there is deficient gap junctional communication [7, 8]. For instance, 
disruption of the function of the gene encoding Cx32 is associated with the 
progressive degeneration of the peripheral nerves, resulting from the impairment 
of the diffusion of nutrients and signalling molecules between the perinuclear 
and periaxonal Schwann cell cytoplasm [for review see [9]. Furthermore, 
abnormalities have been observed in Cx32-deficient mouse livers: Cx32 disruption 
leads to a decrease in the discharge of glucose from glycogen stores [10]. 
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However, the relative non-specificity of the channel allows the passage of a wide 
variety of small molecules, and a multitude of signalling systems affect the 
function of gap junctional channels [11, 12], thus making the mechanistic 
elucidation of the role of gap junctional coupling in tissue homeostasis difficult. 
Cx32 knockout mice appeared to be more susceptible to liver carcinogenesis than 
their wild-type counterparts [13], suggesting that the role of gap junctions during 
the development of tumours may be of special importance. In this paper, the 
state of research on the involvement of gap junctions in the processes of tumour 
arousal and development is outlined. 
 
THE INVOLVEMENT OF GAP JUNCTIONS IN THE REGULATION OF 
TUMOUR CELL PROLIFERATION  
 
Many reports indicate that natural or provoked deficiency in connexin gene 
function correlates with increased cellular susceptibility to transformation. In vivo 
observations indicating the influence of gap junctions on tumorigenesis are 
supported by in vitro data demonstrating the down-regulation of connexin 
expression and gap junction assembly in a wide range of neoplastic cell lines and 
primary tumours [14-17]. Furthermore, viral transfection was shown to reduce 
the levels of gap junctional coupling in cell populations, while a forced 
expression of genes encoding connexins inhibited the proliferation and affected 
the contact behaviour of transfected tumour cells [16]. Retarded tumorigenicity 
was described upon connexin transfection of hepatoma SKHep1, breast 
carcinoma, glioblastoma, PG lung carcinoma, cervical adenocarcinoma HeLa 
and prostate cancer LNCaP cells, which correlated with the inhibition of their 
growth in vitro and in vivo, the decrease of their saturation density, i.e. the 
density attained by cells in culture upon entering the plateau phase [18-20], and 
the inhibition of anchorage-independent growth [21], i.e. the partial reversion of 
the tumour phenotype represented by a decrease in the proliferation rate of 
connexin-transfected tumour cells in semi-solid media [16, 22, 23]. 
An inverse relationship between connexin expression and tumour cell 
proliferation has long been regarded as resulting from the synchronising effect of 
gap junctional coupling on cell physiology. Since the principal role of connexins 
is the formation of intercellular channels, the mechanisms by which connexins 
affect cellular proliferation were originally proposed to depend on the channel-
forming property and gap junction-mediated exchange of putative growth 
inhibitory signals [24, 25]. On the other hand, more recent studies have provided 
evidence for a dissociation of gap junctional coupling intensity and the ability of 
connexins to suppress cell proliferation [26-28]. For example, a direct, coupling-
independent interference of connexins with the signaling pathways involved in 
the regulation of cell proliferation was demonstrated. A down-regulation of 
cyclin D1 upon Cx43 transfection was revealed in human breast tumour cells 
[28] and in normal cell lines [29]. A similar correlation was observed for  
E9 mouse lung carcinoma and osteosarcoma cells [30].  
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Mechanistic studies demonstrated that the exogenous expression of Cx43 might 
exert its inhibitory effect on cell proliferation via the inhibition of the expression 
of S phase kinase-associated protein 2 (skp2), the protein that promotes the 
ubiquitination of cyclin-dependent kinase inhibitor p27kip. A down-regulation 
of cyclin D1 in osteosarcoma cells was shown upon Cx43 transfection, which 
correlated with up-regulation of p27kip [31]. The deletion mutation analyses 
revealed that the C-terminal domain of Cx43 that did not form gap junctions was 
still sufficient to inhibit skp2 expression, while coupling inhibitors did not affect 
the inhibitory effect of Cx43 on skp2 expression, indicating that coupling-
independent mechanisms of Cx43 interfere with the cell cycle [30, 31]. It was 
also recently shown that the phosphorylation of Cx43 on S262 by protein kinase 
C cancels HEK-293 cell growth inhibition by Cx43 independently of the 
channel-forming ability [32]. This finding defines a novel, connexin-dependent 
and gap junctional coupling-independent mechanism for tumour promotion by 
PKCs. Taking all this into account, it would seem that intercellular diffusion of 
putative growth inhibitory factors via gap junctions may play an important role 
during early stages of tumour development in a way complementary to 
mechanisms including direct, coupling-independent interference of connexin 
molecules with signalling pathways regulating the cell cycle.  
 
THE EFFECT OF GAP JUNCTIONS ON THE INVASIVE POTENTIAL 
OF TUMOUR CELLS  
 
In a simplistic model of tumour development, the potentially neoplastic cell, 
when released from the controlling regime of the tissue, begins uncontrolled 
proliferation, thus giving rise to the primary tumour. Gap junctional coupling 
may take part in this process, as impairment of gap junctional communication 
may facilitate this process. On the other hand, some data shows that the function 
of gap junctions may be dependent on the stage of tumorigenesis, i.e. it can 
differ between neoplastic and metastatic cell populations. 
Sequential obligatory steps must be completed after neoplasia (the initial step of 
tumorigenesis) for the occurrence of metastases. Upon detachment from 
neighbouring cells and penetration of natural barriers such as the basement 
membrane and endothelial continuum, neoplastic cells invade blood vessels 
and/or lymphatic vessels in the process known as intravasation, which enables 
them to access the circulatory system. After reaching the bloodstream, tumour 
cells enter the microcirculation and, finally exit the bloodstream by 
extravasation. They then form metastases via expansive growth in the 
parenchyma of the target tissue [33]. Thus, a deregulation of the mechanisms 
determining cell proliferation is followed by the acquisition of the ability of 
unrestricted migration by tumour cells, a prerequisite of invasion [34].  
Although a correlation between the loss of gap junctions and the metastatic 
capability of cancerous cells was reported (see [35]), several studies have 
revealed relatively high levels of connexins and gap junctional coupling in 
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populations of invasive tumour cells. Kamibayashi et al. [36] demonstrated that 
even though the expression of Cx26 and Cx43 was reduced in the early stages of 
mouse skin carcinogenesis, both connexins were expressed on the plasma 
membranes of cells invading the lymph nodes. Similar observations were made 
for breast cancer [35], prostate cancer [37, 38] and glioma cell populations [39]. 
In melanoma cells residing in the basal layer, Cx26 levels remained unchanged, 
but were significantly up-regulated in the cells invading the dermis. 
Furthermore, gap junction formation was observed between melanoma cells and 
mammary adenocarcinoma cells and the endothelium, which could take part in 
the processes of tumour cell intra- and extravasation [40, 41]. Moreover, 
transfection of human cervical carcinoma (HeLa) cells with a gene encoding 
Cx43 significantly increased their in vitro invasive potential [42]. Thus, gap 
junctions and gap junctional coupling facilitates tumour cell invasion in versatile 
cellular models, but the specific mechanisms of the correlation between the 
expression and function of connexins and the metastatic potential of tumour cells 
remain to be determined.  
 
INTERRELATIONS BETWEEN PROLIFERATION, CELL MOTILITY, 
AND GAP JUNCTIONAL COUPLING IN INVASIVE AND NON-
INVASIVE TUMOUR CELL LINES 
 
As mentioned, the invasive potential of tumour cells in vivo is predominantly 
based on their ability to penetrate the endothelial barrier, and to spread and 
proliferate in the adjacent tissue. In order to elucidate how gap junctional 
coupling facilitates tumour invasion, we have established an experimental 
approach enabling the quantitative analyses of connexin expression and the 
function of gap junctions in relation to other cellular traits involved in 
tumorigenesis, such as cell proliferation and motility [43, 44]. This method 
exploits pairs of spontaneously aroused tumour cell lines differing in their 
connexin expression levels and metastatic potential in vivo [37], as well as cell 
lines established through the stable transfection of connexin-deficient tumour 
cell lines with gene(s) encoding particular connexins [42, 45, 46]. Cell 
proliferation and apoptosis was quantified by cell counters and FACS [44], time-
lapse video analysis of cell motility provided statistically significant quantitative 
data on the parameters of tumour cell motility [47, 48], and a calcein spreading 
assay [49] enabled the quantification of gap junctional coupling in homo- and 
heterologous cellular systems. Thus, quantitative analyses of tumour cell 
proliferation, motility and the connexin function of tumour cell lines of common 
origin differing in terms of connexin expression enabled the in vitro 
determination of the interrelations between the cell parameters involved in the 
process of tumorigenesis.  
Using this experimental approach, we compared the properties of two sub-clones 
of HeLa differing in the levels of Cx43 expression and gap junctional coupling, 
namely wild-type HeLa cells and HeLa Cx43 transfectants. Growth curve and 
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time-lapse analyses revealed that both cell lines display similar proliferation 
rates and motility. Since the induction of gap junctional coupling correlates with 
the increased invasive potential of HeLa Cx43 cells, this data indicates that 
Cx43-mediated gap junctional coupling directly affects the invasive properties of 
tumour cells and facilitates the process of metastasis [42, 44]. Similar 
observations have been made for rat prostate cell lines. Highly metastatic MAT-
LyLu cells display significantly higher expressions of Cx43 and coupling levels 
than non-invasive AT-2 cells, while no significant differences in motile activity 
on underlying aligned fibroblasts [37] or in growth rate [50] were observed. 
Thus, cellular systems based on pairs of tumour cell lines differing in the 
intensity of gap junctional coupling [42, 43] are a suitable tool for analyses of 
the influence of gap junctions on tumour development in relation to the tumour 
stage and other cellular traits relevant for tumorigenesis, i.e. cell motility and 
proliferation. 
 
SUMMARY AND OUTLOOK 
 
Evidence exists that the function of gap junctions affects the development of 
tumours in a manner dependent on the stage of tumorigenesis. Gap junctions 
seemingly act as tumour suppressors in the initial stages of this process, while 
the re-expression of connexins in migrating tumour cells may help these cells to 
invade surrounding tissue, and intra- and extravasate (Fig. 2). Interestingly, the 
 
  
Fig. 2. The stage-specific function of gap junctions during tumour development. While the 
loss of connexin expression/function can initiate and promote tumorigenesis in its initial 
stages, the re-expression of connexins and/or re-constitution of their function seem to 
facilitate tumour progression and invasion.   
 
corresponding interrelation has been described for the cells of the immune 
system. Gap junctional coupling between human monocytes and endothelial 
cells seems crucial for monocyte/macrophage transmigration in a blood-brain 
barrier model [51]. Moreover, the expression of three connexin isoforms, namely 
Cx37, Cx40 and Cx43, has been reported in circulating blood cells as well as in 
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vascular endothelial cells [52, 53]. The expression of connexins in blood and 
endothelial cells is modulated by pro-inflammatory agents such as LPS and 
TNF-α [51] and the switch from Cx37/Cx40 to Cx43 expression takes place in 
endothelial cells during inflammation [54]. Thus, gap junctional coupling 
between circulating tumour and endothelial cells may represent a functional link 
between inflammatory processes and the local progression of primary tumours. 
While the correlation between the intensity of gap junctional coupling and the 
invasive potential of blood and tumour cells including their penetration through 
the endothelium seems well documented, the molecular mediators of these 
processes remain unidentified. Since tumour cells are often characterised by 
elevated cytoplasmic calcium levels, and gap junctions mediate the intercellular 
transfer of calcium ions, gap junctional coupling between tumour and 
endothelial cells may elevate calcium concentrations in the endothelium and 
induce the retraction of the endothelial layer, thus reducing its barrier function 
[55]. However, other systems involved in the transmigration of tumour cells can 
be activated by connexin expression, for example those dependent on 
metaloproteinases and cell cycle-related regulatory factors.  
In summary, connexins should be recognised as potential factors determining the 
invasive and metastatic potential of tumour cells. They maintain the intercellular 
communication pathways that malignant cells need in order to overcome tissue 
barriers and invade the surrounding tissues. 
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